Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ELEV

Elevation Oncology (ELEV) Stock Price, News & Analysis

Elevation Oncology logo

About Elevation Oncology Stock (NASDAQ:ELEV)

Advanced Chart

Key Stats

Today's Range
$0.37
$0.37
50-Day Range
$0.36
$0.39
52-Week Range
$0.22
$3.09
Volume
N/A
Average Volume
1.18 million shs
Market Capitalization
$21.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.62
Consensus Rating
Hold

Company Overview

Receive ELEV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevation Oncology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ELEV Stock News Headlines

Elevation Oncology Terminates License Agreement with CSPC
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.tc pixel
See More Headlines

ELEV Stock Analysis - Frequently Asked Questions

Elevation Oncology, Inc. (NASDAQ:ELEV) issued its quarterly earnings data on Thursday, May, 15th. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by $0.04.

Elevation Oncology (ELEV) raised $1 billion in an IPO on Friday, June 25th 2021. The company issued 63,000,000 shares at $15.00-$17.00 per share.

Elevation Oncology's top institutional investors include Opaleye Management Inc. (2.44%), Deltec Asset Management LLC (2.43%), Rangeley Capital LLC (1.53%) and Geode Capital Management LLC (0.91%).
View institutional ownership trends
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevation Oncology investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
5/15/2025
Today
9/13/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ELEV
CIK
1783032
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$0.70
Potential Upside/Downside
+616.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.82)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.49 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-74.68%
Return on Assets
-48.14%

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
19.40
Quick Ratio
19.40

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.02 per share
Price / Book
0.36

Miscellaneous

Outstanding Shares
59,220,000
Free Float
54,427,000
Market Cap
$21.62 million
Optionable
Optionable
Beta
1.48
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ELEV) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners